Clinical Roundup Johns Hopkins study identifies gene mechanism in most aggressive kidney cancers January 06, 2023
Clinical Roundup Imbruvica + venetoclax demonstrates efficacy and sustained response in older patients with previously untreated CLL December 16, 2022Vol.48 No.45
Clinical Roundup Phase III study shows long-term results of Darzalex-based regimen in newly diagnosed, transplant-ineligible MM December 16, 2022Vol.48 No.45
Clinical Roundup Phase II data on Regeneron’s linvoseltamab show clinically meaningful responses in heavily pre-treated MM December 16, 2022Vol.48 No.45
Clinical Roundup Positive phase II data reported on Regeneron’s odronextamab in R/R DLBCL December 16, 2022Vol.48 No.45
Clinical Roundup Kisqali prolonged PFS for metastatic breast cancer vs. chemo December 09, 2022Vol.48 No.44
Clinical Roundup AstraZeneca’s capivasertib + Faslodex demonstrates PFS improvement in breast cancer in phase III trial December 09, 2022Vol.48 No.44
Clinical Roundup Study finds expanded predictive value of Breast Cancer Index for ovarian function suppression in SOFT trial December 09, 2022Vol.48 No.44
Clinical Roundup Race shown to predict survival disparities in head and neck cancer clinical trials December 09, 2022Vol.48 No.44
Clinical Roundup Menthol cigarette alternatives pose significant addiction and health risks December 09, 2022Vol.48 No.44
